Bavarian Nordic data shows booster shot protects against Omicron

Danish biotech firm Bavarian Nordic has demonstrated in a phase II trial that vaccine candidate ABNCoV2 provides protection against the currently dominant Covid-19 variant, Omicron, the company announced in a Thursday press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app